Overview of Drugs in Arterial Thrombosis [and Discussion]
β Scribed by Meade, T. W.; McMichael, J.
- Book ID
- 120152193
- Publisher
- The Royal Society
- Year
- 1981
- Tongue
- English
- Weight
- 409 KB
- Volume
- 294
- Category
- Article
- ISSN
- 0080-4622
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications
## Abstract Drugβeluting stents (DES) seemed likely to mitigate the problem of restenosis and have become the predominant stent deployed during percutaneous coronary intervention (PCI). Sustained concerns about the rate of stent thrombosis (ST), particularly very late ST (>1 year following PCI) led